Site/specimen
|
Test
|
Consideration
|
First pass urine or vaginal swab
|
NAAT/PCR gonorrhoea and chlamydia
|
Based on risk
Self collected
|
Blood
|
HIV antibody/antigen
|
|
Syphilis serology
|
|
Hepatitis C serology
|
Recommended
|
Hepatitis B
Surface antigen (HBsAg), Core antibody (Anti-HBc), Surface antibody (Anti-HBs)
|
Recommended
Vaccinate if no history or no documentation of full vaccination
|
NAAT – nucleic acid amplification test
Specimen collection guidance
Clinician collected | Self-collection
Clinical indicators for testing
- There is no routine testing for other STIs as part of the pre-migration screen.
- Screening should follow standard recommendations and be based on accurate history taking and risk assessment, carefully avoiding assumptions about risk based on gender, ethnicity, religious beliefs or cultural background, visa status or prior entry testing requirements.
- Repeat HIV testing should be offered for adolescents and adults settling from regions of prevalence > 1% (e.g. sub-Saharan Africa, Thailand), for entrants in whom the pre-migration test was months previously, or if other risks are identified on history, as per the HIV National Testing Policy.
- Young people, men who have sex with men and trans and gender diverse people should be offered testing consistent with relevant guidelines.
Special considerations
- Hepatitis B infection is endemic in some migration source countries (particularly in North-East Asia and South-East Asia, and to a lesser extent Europe and sub-Saharan Africa), and is found in 6-16% of refugees in Australia.
- Hepatitis C is curable, and screening is recommended.
- Evidence of prior syphilis infection is common in many parts of Africa and Asia and is commonly detected (5-8%).
- Further information and factsheets about treating patients from culturally and linguistically diverse backgrounds can be found here: http://allgood.org.au/ or https://www.ceh.org.au/resource-hub/
- Accredited interpreters should be used.
- Partners, family or friends must not be used to interpret for a patient due to embarrassment, lack of confidentiality, incorrect translation and medico-legal risks.
- Be aware of cultural sensitivities and stigma in migrant communities. This situation may include non-disclosure of relationships, men who have sex with men and certain sexual practices, and pose additional challenges for contact tracing.
- Gender-based violence, non-consensual and transactional sexual activity are common in conflict zones and refugee camps. Full STI testing should be offered to everyone with this history regardless of age. Consider undisclosed pregnancy.
- People from migrant and refugee backgrounds may have never had cervical screening and should be offered opportunistic testing. Be mindful of possible female genital mutilation (FGM), and facilitating access to affordable gynaecological care if any ongoing management is required.
- Comprehensive contraception choices should be offered. Be mindful of the economic and cultural realities and misbeliefs of patients.
- It is important information is provided in plain language to ensure patients understand testing/diagnosis etc, and that health workers check for comprehension.
- Some sexual health/community services do not require Medicare access and offer free or low-cost services. Refer as needed.
- While most STIs are notifiable to local health departments in Australia, these results are not provided to Immigration. People applying for visas may be required to undertake blood-borne virus testing as part of their health requirement. Further information here